111 related articles for article (PubMed ID: 12520188)
1. Antitumor properties of irinotecan-containing nanoparticles prepared using poly(DL-lactic acid) and poly(ethylene glycol)-block-poly(propylene glycol)-block-poly(ethylene glycol).
Onishi H; Machida Y; Machida Y
Biol Pharm Bull; 2003 Jan; 26(1):116-9. PubMed ID: 12520188
[TBL] [Abstract][Full Text] [Related]
2. Antitumor characteristics of methoxypolyethylene glycol-poly(DL-lactic acid) nanoparticles containing camptothecin.
Miura H; Onishi H; Sasatsu M; Machida Y
J Control Release; 2004 May; 97(1):101-13. PubMed ID: 15147808
[TBL] [Abstract][Full Text] [Related]
3. Preparation and antitumor characteristics of PLA/(PEG-PPG-PEG) nanoparticles loaded with camptothecin.
Kunii R; Onishi H; Machida Y
Eur J Pharm Biopharm; 2007 Aug; 67(1):9-17. PubMed ID: 17337172
[TBL] [Abstract][Full Text] [Related]
4. Particle characteristics and biodistribution of camptothecin-loaded PLA/(PEG-PPG-PEG) nanoparticles.
Kunii R; Onishi H; Ueki K; Koyama K; Machida Y
Drug Deliv; 2008 Jan; 15(1):3-10. PubMed ID: 18197517
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of prolonged-release CPT-11-loaded microspheres in rats.
Machida Y; Onishi H; Kurita A; Hata H; Morikawa A; Machida Y
J Control Release; 2000 May; 66(2-3):159-75. PubMed ID: 10742577
[TBL] [Abstract][Full Text] [Related]
6. Enhanced antitumor effect of camptothecin loaded in long-circulating polymeric micelles.
Kawano K; Watanabe M; Yamamoto T; Yokoyama M; Opanasopit P; Okano T; Maitani Y
J Control Release; 2006 May; 112(3):329-32. PubMed ID: 16678929
[TBL] [Abstract][Full Text] [Related]
7. Polypeptide-based Micelles for Delivery of Irinotecan: Physicochemical and In vivo Characterization.
Ramasamy T; Choi JY; Cho HJ; Umadevi SK; Shin BS; Choi HG; Yong CS; Kim JO
Pharm Res; 2015 Jun; 32(6):1947-56. PubMed ID: 25471199
[TBL] [Abstract][Full Text] [Related]
8. Preparation of irinotecan-loaded folate-targeted liposome for tumor targeting delivery and its antitumor activity.
Zhang Z; Yao J
AAPS PharmSciTech; 2012 Sep; 13(3):802-10. PubMed ID: 22639238
[TBL] [Abstract][Full Text] [Related]
9. Novel anti-tumor strategy: PEG-hydroxycamptothecin conjugate loaded transferrin-PEG-nanoparticles.
Hong M; Zhu S; Jiang Y; Tang G; Sun C; Fang C; Shi B; Pei Y
J Control Release; 2010 Jan; 141(1):22-9. PubMed ID: 19735683
[TBL] [Abstract][Full Text] [Related]
10. Characterization, blood profile and biodistribution properties of surface modified PLGA nanoparticles of SN-38.
Ebrahimnejad P; Dinarvand R; Jafari MR; Tabasi SA; Atyabi F
Int J Pharm; 2011 Mar; 406(1-2):122-7. PubMed ID: 21185365
[TBL] [Abstract][Full Text] [Related]
11. Nanoparticle delivery of an SN38 conjugate is more effective than irinotecan in a mouse model of neuroblastoma.
Iyer R; Croucher JL; Chorny M; Mangino JL; Alferiev IS; Levy RJ; Kolla V; Brodeur GM
Cancer Lett; 2015 May; 360(2):205-12. PubMed ID: 25684664
[TBL] [Abstract][Full Text] [Related]
12. Effect of poly (ethylene oxide)-poly (propylene oxide)-poly (ethylene oxide) micelles on pharmacokinetics and intestinal toxicity of irinotecan hydrochloride: potential involvement of breast cancer resistance protein (ABCG2).
Guo S; Zhang X; Gan L; Zhu C; Gan Y
J Pharm Pharmacol; 2010 Aug; 62(8):973-84. PubMed ID: 20663031
[TBL] [Abstract][Full Text] [Related]
13. Cyclic RGD conjugated poly(ethylene glycol)-co-poly(lactic acid) micelle enhances paclitaxel anti-glioblastoma effect.
Zhan C; Gu B; Xie C; Li J; Liu Y; Lu W
J Control Release; 2010 Apr; 143(1):136-42. PubMed ID: 20056123
[TBL] [Abstract][Full Text] [Related]
14. SN38 polymeric nanoparticles: in vitro cytotoxicity and in vivo antitumor efficacy in xenograft balb/c model with breast cancer versus irinotecan.
Sepehri N; Rouhani H; Tavassolian F; Montazeri H; Khoshayand MR; Ghahremani MH; Ostad SN; Atyabi F; Dinarvand R
Int J Pharm; 2014 Aug; 471(1-2):485-97. PubMed ID: 24879937
[TBL] [Abstract][Full Text] [Related]
15. Irinotecan-encapsulated double-reverse thermosensitive nanocarrier system for rectal administration.
Din FU; Choi JY; Kim DW; Mustapha O; Kim DS; Thapa RK; Ku SK; Youn YS; Oh KT; Yong CS; Kim JO; Choi HG
Drug Deliv; 2017 Nov; 24(1):502-510. PubMed ID: 28181835
[TBL] [Abstract][Full Text] [Related]
16. Folate-mediated solid-liquid lipid nanoparticles for paclitaxel-coated poly(ethylene glycol).
Wu L; Tang C; Yin C
Drug Dev Ind Pharm; 2010 Apr; 36(4):439-48. PubMed ID: 19824865
[TBL] [Abstract][Full Text] [Related]
17. Phospho-valproic acid inhibits pancreatic cancer growth in mice: enhanced efficacy by its formulation in poly-(L)-lactic acid-poly(ethylene glycol) nanoparticles.
Mattheolabakis G; Wang R; Rigas B; Mackenzie GG
Int J Oncol; 2017 Oct; 51(4):1035-1044. PubMed ID: 28849098
[TBL] [Abstract][Full Text] [Related]
18. Preparation and in vitro characterization of dexamethasone-loaded poly(D,L-lactic acid) microspheres embedded in poly(ethylene glycol)-poly({varepsilon}-caprolactone)-poly(ethylene glycol) hydrogel for orthopedic tissue engineering.
Fan M; Guo Q; Luo J; Luo F; Xie P; Tang X; Qian Z
J Biomater Appl; 2013 Aug; 28(2):288-97. PubMed ID: 22561978
[TBL] [Abstract][Full Text] [Related]
19. Preparation and biodisposition of methoxypolyethylene glycol amine-poly(DL-lactic acid) copolymer nanoparticles loaded with pyrene-ended poly(DL-lactic acid).
Sasatsu M; Onishi H; Machida Y
Int J Pharm; 2008 Jun; 358(1-2):271-7. PubMed ID: 18448290
[TBL] [Abstract][Full Text] [Related]
20. Safety and efficacy compared between irinotecan-loaded microspheres HepaSphere and DC bead in a model of VX2 liver metastases in the rabbit.
Namur J; Pascale F; Maeda N; Sterba M; Ghegediban SH; Verret V; Paci A; Seck A; Osuga K; Wassef M; Reb P; Laurent A
J Vasc Interv Radiol; 2015 Jul; 26(7):1067-1075.e3. PubMed ID: 25952641
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
